Financhill
Back

Spyre Therapeutics Quote, Financials, Valuation and Earnings

Spyre Therapeutics Price Quote

$32.98
-0.04 (-3.71%)
(Updated: May 9, 2024 at 6:28 AM ET)

Spyre Therapeutics Key Stats

Sell
42
Spyre Therapeutics (SYRE) is a Sell

Day range:
$31.79 - $34.34
52-week range:
$2.66 - $47.97
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
322.29
P/B ratio:
0%

Volume:
245.1K
Avg. volume:
351.5K
1-year change:
735.95%
Market cap:
$1.2B
Revenue:
$886K
EPS:
$-72.84

How Much Does Spyre Therapeutics Make?

Data Unavailable

Is Spyre Therapeutics Growing As A Company?

Data Unavailable

Spyre Therapeutics Stock Price Performance

What Is Spyre Therapeutics 52-Week High & Low?

Spyre Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Spyre Therapeutics?

Is Spyre Therapeutics Cash Flow Positive?

  • What Is SYRE Cash Flow From Operations?
    Cash flow from operations (TTM) is -$99.9M
  • What Is Spyre Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $361.1M
  • What Is Spyre Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$108.4M

Spyre Therapeutics Return On Invested Capital

Data Unavailable

Spyre Therapeutics Earnings Date & Stock Price

Spyre Therapeutics Competitors

Spyre Therapeutics Dividend Yield

Data Unavailable

Spyre Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -389.13%
Revenue: 0% -100%

Analyst Recommendations

Buy Recommendations: 8
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 43.14
Upside from Last Price: 30.66%

Major Shareholders

  • How many SYRE shares are owned by institutional investors?
    46.8M SYRE shares are owned by institutional investors
  • How many SYRE shares are owned by insiders?
    2.4M SYRE shares are owned by insiders